These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 2118419

  • 21. Selection for methotrexate resistance in mammalian cells bearing a Drosophila dihydrofolate reductase transgene: Methotrexate resistance in transgenic mammalian cells.
    Affleck JG, Nowickyj SM, Walker VK.
    Cell Biol Toxicol; 2010 Apr; 26(2):117-26. PubMed ID: 19337845
    [Abstract] [Full Text] [Related]

  • 22. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
    Domin BA, Grill SP, Cheng Y.
    Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
    [Abstract] [Full Text] [Related]

  • 23. Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.
    Urlaub G, Landzberg M, Chasin LA.
    Cancer Res; 1981 May; 41(5):1594-601. PubMed ID: 7194140
    [Abstract] [Full Text] [Related]

  • 24. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.
    Rosowsky A, Wright JE, Cucchi CA, Lippke JA, Tantravahi R, Ervin TJ, Frei E.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240
    [Abstract] [Full Text] [Related]

  • 25. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB, McIvor RS.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Collateral sensitivity to azidothymidine in methotrexate resistant human leukemia cells.
    Miyachi H, Jiao L, Sowers LC, Scanlon KJ.
    In Vivo; 1992 Nov; 6(1):17-21. PubMed ID: 1385729
    [Abstract] [Full Text] [Related]

  • 32. Carcinogen-mediated methotrexate resistance and dihydrofolate reductase amplification in Chinese hamster cells.
    Kleinberger T, Etkin S, Lavi S.
    Mol Cell Biol; 1986 Jun; 6(6):1958-64. PubMed ID: 3023913
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Differential susceptibility to carcinogen-induced amplification of SV40 and dhfr sequences in SV40-transformed human keratinocytes.
    Rossman TG, Wolosin D.
    Mol Carcinog; 1992 Jun; 6(3):203-13. PubMed ID: 1332730
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Glucocorticoid-induced cell death and poly[adenosine diphosphate(ADP)-ribosyl]ation: increased toxicity of dexamethasone on mouse S49.1 lymphoma cells with the poly(ADP-ribosyl)ation inhibitor benzamide.
    Wielckens K, Delfs T.
    Endocrinology; 1986 Nov; 119(5):2383-92. PubMed ID: 2429833
    [Abstract] [Full Text] [Related]

  • 38. A simple and rapid method for the detection of poly(ADP-ribose) by flow cytometry.
    Ogata S, Okumura K, Taguchi H.
    Biosci Biotechnol Biochem; 2000 Mar; 64(3):510-5. PubMed ID: 10803947
    [Abstract] [Full Text] [Related]

  • 39. Modulation of restriction enzyme-induced damage by chemicals that interfere with cellular responses to DNA damage: a cytogenetic and pulsed-field gel analysis.
    Chung HW, Phillips JW, Winegar RA, Preston RJ, Morgan WF.
    Radiat Res; 1991 Jan; 125(1):107-13. PubMed ID: 1898780
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.